Symbols

PYXS

Pyxis Oncology·NASDAQ

--(--)

PYXS fundamentals

PYXS Q3 2025 Earnings

Pyxis Oncology (PYXS) released its earnings on Nov 3, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.35 (YoY 0.00%), missed estimates.

Revenue / YoY

EPS / YoY

-0.35

0.00%

Report date

Nov 3, 2025

Earnings

EPS

Revenue

Revenue & Expenses

PYXS has released its 2025 Q4 earnings report, with revenue of 11.04M, reflecting a YoY change of NaN%, and net profit of -18.11M, showing a YoY change of 49.10%. The Sankey diagram below clearly presents PYXS's revenue sources and cost distribution.

Key Indicators

Pyxis Oncology (PYXS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Pyxis Oncology (PYXS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Pyxis Oncology (PYXS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Pyxis Oncology (PYXS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown